Dizocilpine-induced accuracy deficits in a visual signal detection task are not present following d-cycloserine administration in rats

European Journal of Pharmacology

Volumn 577, Issue 1-3, 2007, Pages 87-90

  Howe, W Matthew ^a   Burk, Joshua A ^a  

^a Dept of Economics and Thomas Jefferson Program in Public Policy at the College of William and Mary   (United States)

Author keywords

Glutamate; MK 801; Schizophrenia; Vigilance

Indexed keywords

CYCLOSERINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG DOSE REGIMEN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; SINGLE DRUG DOSE; VISION; VISUAL DISCRIMINATION;

ANIMALS; ANTIMETABOLITES; BINDING SITES; CYCLOSERINE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL DETECTION (PSYCHOLOGY); VISUAL PERCEPTION;

EID: 35448934103     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.037     Document Type: Article

References (27)

1. Adler C.M., Malhotra A.K., Elman I., Goldberg T., Egan M., Pickar D., and Breier A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am. J. Psychiatry 156 (1999) 1646-1649
2. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 19 (1993) 233-259
3. Burk J.A. Introduction of a retention interval in a sustained attention task in rats: effects of presenting a visual distracter and increasing the inter-trial interval. Behav. Processes 67 (2004) 521-531
4. Burk J.A., and Sarter M. Dissociation between the attentional functions mediated via basal forebrain cholinergic and GABAergic neurons. Neuroscience 105 (2001) 899-909
5. Deller T., and Sarter M. Effects of repeated administration of amphetamine on behavioral vigilance: evidence for "sensitized" attentional impairments. Psychopharmacology 137 (1998) 410-414
6. Giovannini M.G., Giovannelli L., Bianchi L., Kalfin R., and Pepeu G. Glutamatergic modulation of cortical acetylcholine release in the rat: a combined in vivo microdialysis, retrograde tracing, and immunohistochemical study. Eur. J. Neurosci. 9 (1997) 1678-1689
7. Green M., and Walker E. Attentional performance in positive- and negative-symptom schizophrenia. J. Nerv. Ment. Dis. 174 (1986) 208-213
8. Haroutunian V., Dracheva S., and Davis K.L. Neurobiology of glutamatergic abnormalities in schizophrenia. Clin. Neurosci. Res. 3 (2003) 67-76
9. Heresco-Levy U., Ermilov M., Shimoni J., Shapira J., Shapira B., Silipo G., and Javitt D.C. Placebo-controlled trial of d-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. Am. J. Psychiatry 159 (2002) 480-482
10. Holley L.A., Turchi J., Apple C., and Sarter M. Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain. Psychopharmacology 120 (1995) 99-108
11. Javitt D.C. Glycine modulators in schizophrenia. Curr. Opin. Investig. Drugs 3 (2002) 1067-1072
12. Kondrad R.L., and Burk J.A. Transient disruption of attentional performance following escalating amphetamine administration in rats. Psychopharmacology 175 (2004) 436-442
13. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res. Rev. 31 (2000) 371-384
14. Malhotra A.K., Pinals D.A., Weingartner H., Sirocco K., Missar C.D., Pickar D., and Breier A. NMDA receptor function and human cognition: the effects of ketamine on healthy volunteers. Neuropsychopharmacology 14 (1996) 301-307
15. McGaughy J., Kaiser T., and Sarter M. Behavioral vigilance following infusions of 192IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 110 (1996) 247-265
16. McGaughy J., and Sarter M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology 117 (1995) 340-357
17. McGhie A., and Chapman J. Disorders of attention and perception in early schizophrenia. Int. J. Med. Psychol 34 (1961) 103-116
18. Nelson C.L., Sarter M., and Bruno J.P. Repeated pretreatment with amphetamine sensitizes cortical acetylcholine release. Psychopharmacology 151 (2000) 406-415
19. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., Craft S., and Olney J.W. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20 (1999) 106-118
20. Ohnuma T., Suzuki T., and Arai H. Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 889-894
21. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. 33 (1999) 523-533
22. Rezvani A.H., and Levin E.D. Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats. Eur. J. Pharmacol. 465 (2003) 83-90
23. Sarter M., Hasselmo M.E., Bruno J.P., and Givens B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res. Rev. 48 (2005) 98-111
24. Sarter M., Nelson C.L., and Bruno J.P. Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophr. Bull. 31 (2005) 117-138
25. Tsai G., van Kammen D.P., Chen S., Kelley M.E., Grier A., and Coyle J.T. Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia. Biol. Psychiatry 44 (1998) 667-674
26. Tuominen H.J., Tiihonen J., and Wahlbeck K. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 72 (2005) 225-234
27. Turchi J., and Sarter M. Bidirectional modulation of basal forebrain N-methyl-d-aspartate receptor function differentially affects visual attention but not visual discrimination performance. Neuroscience 104 (2001) 407-417